Skip to main content

PROSPECTIVE, LONGITUDINAL, NON-INTERVENTIONAL STUDY OF DISEASE BURDEN AND TREATMENT OF PATIENTS WITH LOW-RISK MYELOFIBROSIS (MF) OR HIGH-RISK ESSENTIAL THROMBOCYTHEMIA (ET) OR ET PATIENTS RECEIVING ET-DIRECTED THERAPY

Research Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

October 2, 2017

End Date

December 28, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

October 2, 2017

End Date

December 28, 2023